A first-in-class, non-invasive, immunodynamic biomarker approach for precision immuno-oncology

Non-invasive, immuno-dynamic, biomarkers positioned in cancer patient’s blood milieu with immuno-oncological applications are rare. We recently established a “first-in-class” serum functional immunodynamics status (sFIS) assay, wherein in vitro assessment of serum-induced myeloid NFkB and/or interfe...

Descripción completa

Detalles Bibliográficos
Autores principales: Sprooten, Jenny, Coosemans, An, Garg, Abhishek D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757472/
https://www.ncbi.nlm.nih.gov/pubmed/35036075
http://dx.doi.org/10.1080/2162402X.2021.2024692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757472/
https://www.ncbi.nlm.nih.gov/pubmed/35036075
http://dx.doi.org/10.1080/2162402X.2021.2024692

Ejemplares similares